These injections are typically administered in clinical settings as part of a broader weight management plan, often in combination with dietary changes and physical activity
However, a systematic review of this emerging field remains lacking, one that elucidates its scientific basis, technical pathways, preclinical evidence, and clarifies its translational prospects
What's the basic mechanism difference
however, individuals already taking glucose-lowering medicines (including insulin) may be at increased risk of hypoglycaemia if GH-mediated effects alter their insulin sensitivity Injection site reactions, including pain, redness, and infection risk For retatrutide , the side effect profile observed in clinical trials is consistent with that of other GLP-1 receptor agonists and includes nausea, vomiting, diarrhoea, and constipation